Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Erlotinib | 19.9526 | uM | 10 | 156.25 | 46.73 | 403.00 | 95.00 | 4.2421 | 7.2055 |
| BT-20 | Methotrexate | 0.31623 | uM | 3 | 625.00 | 278.42 | 2494.00 | 571.50 | 4.3640 | 7.2752 |
| BT-20 | Nilotinib | 19.9526 | uM | 5 | 312.50 | 145.00 | 853.00 | 259.25 | 3.2903 | 7.2801 |
| Hs 578T | 0 | uM | 1 | 1250.00 | 718.46 | 1166.00 | 841.82 | 1.3851 | 7.3161 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 116.00 | 77.00 | 1.5065 | 7.3341 | |
| BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 113.00 | 60.50 | 1.8678 | 7.3342 | |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 156.25 | 63.10 | 115.00 | 76.75 | 1.4984 | 7.3723 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 110.00 | 89.00 | 1.2360 | 7.3999 | |
| BT-20 | Nilotinib | 19.9526 | uM | 3 | 312.50 | 136.54 | 1318.00 | 285.25 | 4.6205 | 7.4410 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 4 | 156.25 | 63.10 | 120.00 | 77.75 | 1.5434 | 7.4526 |
| BT-20 | Nilotinib | 10 | uM | 3 | 156.25 | 49.48 | 484.00 | 103.75 | 4.6651 | 7.4562 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 100.00 | 86.25 | 1.1594 | 7.4871 | |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 156.25 | 80.34 | 100.00 | 86.25 | 1.1594 | 7.4871 |
| SK-BR-3 | Nilotinib | 10 | uM | 5 | 312.50 | 138.75 | 787.00 | 243.50 | 3.2320 | 7.4899 |
| Hs 578T | Palbociclib | 19.9526 | uM | 10 | 156.25 | 66.59 | 211.00 | 96.50 | 2.1865 | 7.6267 |
| MDA-MB-231 | Nilotinib | 19.9526 | uM | 11 | 625.00 | 241.23 | 2358.00 | 501.75 | 4.6996 | 7.6517 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 5 | 312.50 | 138.75 | 801.00 | 243.50 | 3.2895 | 7.6764 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 118.00 | 77.00 | 1.5325 | 7.8454 | |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 5 | 312.50 | 138.75 | 798.00 | 242.00 | 3.2975 | 7.8457 |
| BT-20 | Nilotinib | 10 | uM | 3 | 156.25 | 49.48 | 453.00 | 100.00 | 4.5300 | 7.8586 |
| SK-BR-3 | Methotrexate | 1 | uM | 3 | 156.25 | 80.34 | 113.00 | 89.50 | 1.2626 | 7.9402 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 3 | 156.25 | 80.34 | 113.00 | 89.50 | 1.2626 | 7.9402 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 113.00 | 89.50 | 1.2626 | 7.9402 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 79.00 | 67.75 | 1.1661 | 7.9542 | |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 4 | 156.25 | 63.10 | 115.00 | 76.25 | 1.5082 | 8.0098 |